Board Certified Podiatrists | Expert Foot & Ankle Care
(810) 206-1402 Patient Portal

Best Toenail Fungus Treatment: Ranked by Evidence (2026)

Medically reviewed by Dr. Tom Biernacki, DPM

Board-certified podiatric surgeon | Balance Foot & Ankle, Howell & Bloomfield Hills, MI
Last reviewed: May 2026

MICHIGAN PODIATRIST INSIGHT

Choosing the right Toenail Fungus Treatment: Ranked by Evidence () depends on one clinical variable our podiatrists assess before any product recommendation — and most online comparisons never mention it. Getting this wrong is the most common reason patients cycle through multiple products without relief. Call (810) 206-1402 — expert podiatric care across Michigan.

Best Toenail Fungus Treatment - Michigan podiatrist, Balance Foot & Ankle
Best Toenail Fungus Treatment treatment | Balance Foot & Ankle, Michigan
TreatmentMycological Cure RateComplete Cure RateCourse LengthBest For
Terbinafine oral (Lamisil) — generic70–80%38–59%12 weeksDermatophyte onychomycosis (T. rubrum); most cases
Itraconazole oral (pulse dosing)54–70%35–50%3 monthly pulsesWhen terbinafine not tolerated; broader spectrum (Candida)
Fluconazole oral (weekly)48–62%25–40%6–12 monthsCandida onychomycosis; terbinafine intolerance
Efinaconazole topical (Jublia 10%)55%18%48 weeks dailyMild–moderate; liver disease; drug interactions; patient preference
Tavaborole topical (Kerydin 5%)31–36%7%48 weeks dailyLimited nail involvement; cannot take oral
Ciclopirox topical (Penlac 8%)29–36%5–8%48 weeks dailyEarly/superficial infections; adjunct to oral
Laser treatment (Nd:YAG 1064nm)30–60%Variable3–4 sessionsOral contraindicated; adjunct for refractory cases
Combination oral + topicalHigher than either aloneHigherPer componentSevere disease; previous treatment failure; diabetic patients
Patient ProfileBest Treatment ChoiceWhy
Healthy adult; confirmed dermatophyte; 1–3 nails; <50% involvementOral terbinafine 250mg x 12 weeksHighest cure rate; shortest course; inexpensive generic; well-tolerated
Confirmed dermatophyte; >50% involvement; thickened nailsOral terbinafine + topical efinaconazoleCombination improves outcomes for extensive disease
Liver disease or significant drug interactions (e.g., warfarin, cyclosporine)Topical efinaconazole (Jublia) 48 weeksNo systemic absorption; no liver metabolism; no drug interactions
Fingernail involvement or Candida onychomycosisOral itraconazole pulse x 3 or fluconazole weeklyBetter Candida coverage than terbinafine; fingernails respond faster
Previous oral antifungal failure; severe or refractory diseaseRepeat oral (confirm culture) + laser adjunctCulture identifies resistant species or misdiagnosis; laser adds non-pharmacologic pressure
Mild superficial white onychomycosis onlyTopical ciclopirox or efinaconazoleSurface-only infection most topical-accessible; oral may be avoided
Diabetic patient; multiple nails; high infection riskOral terbinafine + meticulous foot hygiene + podiatric monitoringHigh infection risk warrants effective oral treatment; podiatric supervision for wound prevention

Choosing the Best Toenail Fungus Treatment

The “best” toenail fungus treatment depends on the extent of infection, the causative organism, the patient’s health status and medications, and whether topical vs. oral therapy is appropriate. One answer applies to most patients with confirmed dermatophyte toenail fungus: oral terbinafine (generic Lamisil) is the most effective available treatment with the strongest clinical evidence, the highest cure rates, the shortest treatment course, and the lowest cost.

No products found.

Oral Terbinafine (Lamisil): Why It’s the Gold Standard

Oral terbinafine (brand name Lamisil; widely available as generic) is an allylamine antifungal that works by inhibiting squalene epoxidase, an enzyme in the fungal sterol synthesis pathway, causing accumulation of toxic squalene that kills the fungus. It achieves nail concentrations via the bloodstream and nail matrix, bypassing the nail penetration problem that limits topical agents. The standard course is 250mg daily for 12 weeks for toenail infections. Cure rates from multiple randomized controlled trials: mycological cure (lab evidence the fungus is gone) 70–80%; complete cure (clear nail + negative culture) 38–59%. The remaining patients who are mycologically cured but don’t achieve complete nail clearance have often killed the fungus but are waiting for the nail to fully grow out — which takes 12–18 months after the drug is stopped.

Terbinafine is generally well-tolerated. The most common side effects are GI (nausea, diarrhea, abdominal discomfort) in 5–10% of patients, and taste disturbances in 2–3% — an unusual but distinctive side effect (metallic taste; altered or diminished taste sensation) that resolves after stopping the medication. Rare hepatotoxicity (liver injury) has been reported; routine liver function tests are not required in healthy patients taking a 12-week course, but patients with pre-existing liver disease should use a different treatment. Terbinafine interacts with CYP2D6 substrates (some antidepressants, beta-blockers, antipsychotics) — a medication review before prescribing is important.

Prescription Topicals: When Oral Isn’t an Option

FDA-approved prescription topical antifungals are an important option for patients who cannot take oral antifungals (due to liver disease, drug interactions, or patient preference). Efinaconazole (Jublia 10%) was specifically engineered with low nail binding affinity to achieve high transungual penetration — and is the most effective topical with mycological cure rates of approximately 55% at 48 weeks of daily application. It is pregnancy category C and has no significant drug interactions. It is applied once daily to the entire affected nail and 5mm of surrounding skin. Tavaborole (Kerydin 5%) has lower cure rates (31–36%) but uses a boron-containing molecule with different penetration chemistry. Ciclopirox (Penlac 8%) is the oldest prescription topical with the lowest cure rates (29–36%) but some evidence as an oral adjunct. All topicals require consistent daily application for 48 weeks — adherence is the major practical challenge.

Why Treatment “Fails”: The Most Common Reasons

Toenail fungus treatment frequently appears to fail for predictable, preventable reasons. The most common: treating without confirming the diagnosis. Approximately 50% of nail dystrophy (abnormal-looking nails) is not fungal — it’s nail psoriasis, trauma, lichen planus, or other non-infectious causes that won’t respond to any antifungal. Nail culture or KOH testing before treatment is the single most important step to avoid months of ineffective treatment. The second most common reason: shoe reservoir re-infection. Old shoes harbor live dermatophyte spores for months and re-infect treated nails. After completing treatment, replace or decontaminate heavily-worn footwear. Third: untreated concurrent tinea pedis (athlete’s foot) on the surrounding skin provides a continuous source of fungal re-seeding to the nails.

At Balance Foot & Ankle, Dr. Tom Biernacki and Dr. Carl Jay provide in-office nail culture, KOH testing, prescription antifungal treatment, and laser therapy for toenail fungus at both the Howell and Bloomfield Hills offices. Call (810) 206-1402.

American Academy of Dermatology: Nail Fungus

Ready to Get Relief?

Same-day appointments available in Howell & Bloomfield Hills, MI

4.9★ | 1,123 Reviews | 3,000+ Surgeries

Or call: (810) 206-1402

For a complete clinical overview: Toenail Fungus Complete Treatment Guide — oral, topical, laser and home remedy evidence reviewed

Balance Foot & Ankle surgeons are affiliated with Trinity Health Michigan, Corewell Health, and Henry Ford Health — three of Michigan’s largest health systems.